BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8871610)

  • 1. Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis.
    Zhang X; Li L; Choe J; Krajewski S; Reed JC; Thompson C; Choi YS
    Cell Immunol; 1996 Oct; 173(1):149-54. PubMed ID: 8871610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic expression of Bcl-2, but not Bcl-xL rescues Ramos B cells from Fas-mediated apoptosis.
    Alam MK; Davison S; Siddiqui N; Norton JD; Murphy JJ
    Eur J Immunol; 1997 Dec; 27(12):3485-91. PubMed ID: 9464838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-x protects primary B cells against Fas-mediated apoptosis.
    Schneider TJ; Grillot D; Foote LC; Núñez GE; Rothstein TL
    J Immunol; 1997 Nov; 159(10):4834-9. PubMed ID: 9366408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
    Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
    J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells.
    Wang Z; Karras JG; Howard RG; Rothstein TL
    J Immunol; 1995 Oct; 155(8):3722-5. PubMed ID: 7561075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of Fas antigen on activated murine B cells.
    Wang J; Taniuchi I; Maekawa Y; Howard M; Cooper MD; Watanabe T
    Eur J Immunol; 1996 Jan; 26(1):92-6. PubMed ID: 8566089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression.
    Li L; Krajewski S; Reed JC; Choi YS
    Cell Immunol; 1997 May; 178(1):33-41. PubMed ID: 9184696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren's syndrome.
    Nakamura H; Kawakami A; Tominaga M; Migita K; Kawabe Y; Nakamura T; Eguchi K
    Lab Invest; 1999 Mar; 79(3):261-9. PubMed ID: 10092062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells.
    Choi MS; Boise LH; Gottschalk AR; Quintans J; Thompson CB; Klaus GG
    Eur J Immunol; 1995 May; 25(5):1352-7. PubMed ID: 7539757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular factors that regulate the differentiation and apoptosis of germinal center B cells. Anti-Ig down-regulates Fas expression of CD40 ligand-stimulated germinal center B cells and inhibits Fas-mediated apoptosis.
    Choe J; Kim HS; Zhang X; Armitage RJ; Choi YS
    J Immunol; 1996 Aug; 157(3):1006-16. PubMed ID: 8757604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax.
    Aggarwal S; Gupta S
    J Immunol; 1998 Feb; 160(4):1627-37. PubMed ID: 9469419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
    Moreno MB; Memon SA; Zacharchuk CM
    J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule.
    Lagresle C; Bella C; Daniel PT; Krammer PH; Defrance T
    J Immunol; 1995 Jun; 154(11):5746-56. PubMed ID: 7538529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced susceptibility to Fas-mediated apoptosis in B-1 cells.
    Masuda K; Wang J; Watanabe T
    Eur J Immunol; 1997 Feb; 27(2):449-55. PubMed ID: 9045916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma.
    Memon SA; Moreno MB; Petrak D; Zacharchuk CM
    J Immunol; 1995 Nov; 155(10):4644-52. PubMed ID: 7594463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells.
    Cleary AM; Fortune SM; Yellin MJ; Chess L; Lederman S
    J Immunol; 1995 Oct; 155(7):3329-37. PubMed ID: 7561026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strength of signal through BCR determines the fate of cycling B cells by regulating the expression of the Bcl-2 family of survival proteins.
    Pittner BT; Snow EC
    Cell Immunol; 1998 May; 186(1):55-62. PubMed ID: 9637765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant signals leading to inhibitor kappaB protein degradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis.
    Schauer SL; Bellas RE; Sonenshein GE
    J Immunol; 1998 May; 160(9):4398-405. PubMed ID: 9574544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.